A pH-responsive complex based on supramolecular organic framework for drug-resistant breast cancer therapy

Mostrar otras versiones (1)

Chemotherapy is one of the main ways to treat breast cancer clinically. However, the multidrug resistance to anti-tumor drugs limits their clinical use. To overcome these drawbacks, development of drug delivery systems (DDSs) has attracted more and more attention in cancer therapy. At present, the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yun-Chang, Zeng, Pei-Yu, Ma, Zhi-Qiang, Xu, Zi-Yue, Wang, Ze-Kun, Guo, Beibei, Yang, Feng, Li, Zhan-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725931/
https://www.ncbi.nlm.nih.gov/pubmed/34967270
http://dx.doi.org/10.1080/10717544.2021.2021325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725931/
https://www.ncbi.nlm.nih.gov/pubmed/34967270
http://dx.doi.org/10.1080/10717544.2021.2021325

Ejemplares similares